期刊文献+

深圳市妇女宫颈癌组织中人乳头瘤病毒16型E6、E7致癌基因的序列分析 被引量:3

Sequencing analysis of HPV 16 E6/E7 gene extracted from cervical cancer tissues from female patient in Shenzhen
暂未订购
导出
摘要 目的检测深圳市宫颈癌患者癌组织中HPV16型E6、E7致癌基因的序列。方法采用PCR技术扩增1例在深圳生活17年宫颈癌HPV16型阳性患者组织中HPV16E6、E7基因,对其进行克隆、构建重组质粒并进行核酸限制性内切酶鉴定及DNA测序分析。结果成功地克隆了HPV16E6、E7基因,测序分析表明克隆的HPV16E6、E7基因与GenBank收录的德国标准株相比完全一致。结论深圳市妇女宫颈癌组织中HPV16型E6、E7致癌基因的序列与德国标准株相同。 Objective To investigate the coding sequences of HPV16 E6/E7 gene extracted from the cervical cancer tissues from patients in Shenzhen.Methods The HPV16 E6/E7 gene was extracted from a HPV16 positive cervical cancer patient that had been living in Shenzhen for 17 years.The gene was amplified by PCR and cloned;the recombinant plasmid was constructed;and the DNA Sequence was restricted by restriction endonuclease.Results The HPV16 E6/E7 gene was successfully cloned and the sequencing analysis showed that the cloned HPV16 E6/E7 gene is identical to the German standard strain documented in GenBank.Conclusion The coding of HPV16 E6/E7 gene extracted from cervical cancer tissues from female patient in Shenzhen is identical to the German standard strain.
出处 《中国实验诊断学》 2014年第3期397-400,共4页 Chinese Journal of Laboratory Diagnosis
基金 深圳市科技局立项课题(医疗卫生类)(201003042)
关键词 宫颈癌 人乳头瘤病毒 E6、E7致癌基因 序列分析 cervical cancer human papillomavirus (HPV) E6 oncogene, E7 oncogene sequence analysis
  • 相关文献

参考文献12

  • 1Gr Instein E,Wernet P,Sn Ijders PJF,et al. Nucleolin as Activa tor of Human Papillomavirus Type 18 Oncogene Transcription in Cervical Cancer[J]. J Exp Med, 2002,196(8): 1067.
  • 2Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution[J]. Virology, 2005,337(1) ;76.
  • 3Khan MJ, Castle PE, Lorincz AT, Waeholder S, Sherman M, et al. The elevated 10 year risk of cervical precaneer and cancer in women with,tuman papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice [J]. J Natl Cancer Inst,2005,97(14) : 1072.
  • 4Jonat hor P. P21 inhibits cyclin shock[J]. Nature, 1994,369(16) : 520.
  • 5Mahdav IA, Monk B J. Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges[J]. Oncologist, 2005(10) :528.
  • 6Barbosa M S, Lowy D R, Schiller J T. Papillomavirus polypep- tides E6 E7 are zincbinding proteins[J]. J Virol, 1998,63 : 1404.
  • 7Song S Y, Pitot H C, Lambert P F. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in trans genic animals[J]. J Virol, 1999,73(7) .. 5887.
  • 8Zehbe I, Wilander E, Delius H, Tommasino M. Human papilloma virus 16 E6 variants are more prevalent in invasivecervical carci noma than the prototype[J]. Cancer Res,1998,58(4):829.
  • 9Matsumoto K, Yoshikawa H, Nakagawa S, et al. Enhanced onco genicity of human papillomavirus type 16 (HPV16) variants in Japanese population[J]. Cancer Lett,2000,156(2) : 159.
  • 10Pande S,Jain N, Prusty BK, et al. Human papillomavirus type 16 variant analysis of E6, E7,and L1 genes and long control re- gion in biopsy samples from cervical cancer patients in north In dia[J]. J Clin Microbiol,2008,46(3) : 1060.

二级参考文献10

共引文献14

同被引文献23

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部